CRT 2024

Diversity, Equity & Inclusion in CV Device Evaluation

Panel Discussant(s)

• 

  Wayne Batchelor, MD, MHS

  Director, Interventional Cardiology and Interventional Research and Innovation
  Inova Heart & Vascular Institute
  Falls Church, Virginia, United States

  No relationships to disclose
• BC

  Brittany Caldwell

  Disclosure information not submitted.
• 

  Megan Coylewright, MD, MPH

  Vice Chief of Cardiology and Director of Structural Heart Program
  The Erlanger Heart and Lung Institute
  Chattanooga, Tennessee, United States

  No relationships to disclose
• 

  Michael R. Jaff, DO

  Chief Medical Officer
  Boston Scientific Corporation
  Delray Beach, Florida, United States

  Disclosure information not submitted.
• JR

  Jennifer Rymer, MD

  Interventional cardiologist
  Duke, North Carolina, United States

  Disclosure(s): Abiomed Inc: Contracted Research (Ongoing); Chiesi Inc: Advisor (Ongoing), Contracted Research (Ongoing); idorsia pharmaceuticals: Clinical Trial Investigator (Ongoing); Novo Nordisk: Clinical Trial Investigator (Ongoing), Contracted Research (Ongoing)
• DS

  Dan Stephens

  Disclosure information not submitted.